[Mouse neurovirulence of antigenic chimeras (type I/II) of polioviruses]

C Dai1

  • 1Institute of Medical Biology, Kunming.

Insights

Neutralization antigenic site I (N-Ag1) on poliovirus determines mouse neurovirulence. Replacing specific amino acids in poliovirus type 1 with poliovirus type 2 sequences induced disease in mice, confirming N-Ag1

Area of Science:

  • Virology
  • Neuroscience
  • Immunology

Context:

  • Poliovirus type 2 (PV-2) Lansing strain causes fatal neurovirulence in mice, unlike poliovirus type 1 (PV-1) Mahoney strain.
  • Previous research implicated the 5' non-translated region and neutralization antigenic site I (N-Ag1) in PV-2 mouse neurovirulence.

Purpose:

  • To investigate the specific role of N-Ag1 in poliovirus mouse neurovirulence.
  • To construct and test chimeric poliovirus strains with modified N-Ag1 sequences.

Summary:

  • Antigenic chimeras (XF414 and XF324) were created by replacing PV-1 N-Ag1 sequences with PV-2 specific sequences.
  • Intracerebral inoculation of these chimeric viruses into mice resulted in poliomyelitis, paralysis, and death.
  • Infected mice yielded viruses with the antigenicity of the inoculated chimeric strains, confirming viral replication.

Impact:

  • Demonstrates that N-Ag1 is a critical determinant of poliovirus host range and neurovirulence in mice.
  • Suggests N-Ag1 may play a role in the attachment and entry mechanisms of poliovirus into the mouse central nervous system.
  • Provides insights into viral adaptation and pathogenesis, relevant for understanding poliovirus evolution and control strategies.